Publications by authors named "Carolyn Marie Ervin"
Lancet Neurol
August 2018
Article Synopsis
- Fingolimod, a treatment for relapsing-remitting multiple sclerosis, was studied for its effectiveness in delaying disability progression in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who stopped other treatments like IVIg or corticosteroids.
- This double-blind, multi-center trial involved 106 participants across various countries and compared the effects of oral fingolimod versus a placebo over a flexible treatment duration of up to 4.5 years.
- The primary goal was to measure the time until the first confirmed worsening of disability, using the INCAT disability scale, with results analyzed via survival distribution functions.
